Other studies indicated that MSC-Exo-derived miR-126 could suppress hyperglycemia-induced inflammation by down-regulating HMGB1, which can bind to TLRs and activate the NLRP3 pathway (Zhang et al., 2019c). The gene discussed is NLRP3; the disease is Hyperglycemia.